Shining More Light on RAS Inhibition during the COVID-19 Pandemic.
Publication
, Journal Article
Rianto, F; Sparks, MA
Published in: Clin J Am Soc Nephrol
July 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin J Am Soc Nephrol
DOI
EISSN
1555-905X
Publication Date
July 2021
Volume
16
Issue
7
Start / End Page
1002 / 1004
Location
United States
Related Subject Headings
- Urology & Nephrology
- Severity of Illness Index
- SARS-CoV-2
- Humans
- Clinical Trials as Topic
- COVID-19
- Angiotensin-Converting Enzyme Inhibitors
- Angiotensin-Converting Enzyme 2
- Angiotensin Receptor Antagonists
- 4202 Epidemiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Rianto, F., & Sparks, M. A. (2021). Shining More Light on RAS Inhibition during the COVID-19 Pandemic. Clin J Am Soc Nephrol, 16(7), 1002–1004. https://doi.org/10.2215/CJN.06000521
Rianto, Fitra, and Matthew A. Sparks. “Shining More Light on RAS Inhibition during the COVID-19 Pandemic.” Clin J Am Soc Nephrol 16, no. 7 (July 2021): 1002–4. https://doi.org/10.2215/CJN.06000521.
Rianto F, Sparks MA. Shining More Light on RAS Inhibition during the COVID-19 Pandemic. Clin J Am Soc Nephrol. 2021 Jul;16(7):1002–4.
Rianto, Fitra, and Matthew A. Sparks. “Shining More Light on RAS Inhibition during the COVID-19 Pandemic.” Clin J Am Soc Nephrol, vol. 16, no. 7, July 2021, pp. 1002–04. Pubmed, doi:10.2215/CJN.06000521.
Rianto F, Sparks MA. Shining More Light on RAS Inhibition during the COVID-19 Pandemic. Clin J Am Soc Nephrol. 2021 Jul;16(7):1002–1004.
Published In
Clin J Am Soc Nephrol
DOI
EISSN
1555-905X
Publication Date
July 2021
Volume
16
Issue
7
Start / End Page
1002 / 1004
Location
United States
Related Subject Headings
- Urology & Nephrology
- Severity of Illness Index
- SARS-CoV-2
- Humans
- Clinical Trials as Topic
- COVID-19
- Angiotensin-Converting Enzyme Inhibitors
- Angiotensin-Converting Enzyme 2
- Angiotensin Receptor Antagonists
- 4202 Epidemiology